110 related articles for article (PubMed ID: 17631268)
1. Photodynamic therapy with verteporfin for corneal neovascularization.
Yoon KC; You IC; Kang IS; Im SK; Ahn JK; Park YG; Ahn KY
Am J Ophthalmol; 2007 Sep; 144(3):390-395. PubMed ID: 17631268
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization.
You IC; Im SK; Lee SH; Yoon KC
Cornea; 2011 Jan; 30(1):30-3. PubMed ID: 20861729
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin for corneal neovascularization.
Al-Torbak AA
Middle East Afr J Ophthalmol; 2012; 19(2):185-9. PubMed ID: 22623856
[TBL] [Abstract][Full Text] [Related]
4. [Corneal neovascularisation treatments compared: Subconjunctival bevacizumab injections and/or photodynamic therapy].
Hamdan J; Boulze M; Aziz A; Alessi G; Hoffart L
J Fr Ophtalmol; 2015 Dec; 38(10):924-33. PubMed ID: 26522892
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome.
Yoon HJ; Kim MK; Seo KY; Ueta M; Yoon KC
Int Ophthalmol; 2019 Jan; 39(1):55-62. PubMed ID: 29256167
[TBL] [Abstract][Full Text] [Related]
6. [Neovascularization corneal regression in patients treated with photodynamic therapy with verteporfin].
Díaz-Dávalos CD; Carrasco-Quiroz A; Rivera-Díez D
Rev Med Inst Mex Seguro Soc; 2016; 54(2):164-9. PubMed ID: 26960043
[TBL] [Abstract][Full Text] [Related]
7. Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin.
Yoon KC; Ahn KY; Lee SE; Kim KK; Im SK; Oh HJ; Jeong IY; Park SW; Park YG; Nah HJ; Im WB
Curr Eye Res; 2006 Mar; 31(3):215-24. PubMed ID: 16531278
[TBL] [Abstract][Full Text] [Related]
8. Recurrent herpes simplex keratitis after verteporfin photodynamic therapy for corneal neovascularization.
Yoon KC; Im SK; Park HY
Cornea; 2010 Apr; 29(4):465-7. PubMed ID: 20164757
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
12. Resolution of bilateral corneal neovascularization and lipid keratopathy after photodynamic therapy with verteporfin.
Al-Abdullah AA; Al-Assiri A
Optometry; 2011 Apr; 82(4):212-4. PubMed ID: 21216676
[TBL] [Abstract][Full Text] [Related]
13. [Photodynamic therapy with verteporfirin in corneal neovascularization].
Verdiguel-Sotelo K; Hernández-López A; González-Camarena PI; Devereux-García R; Pineda-Espinosa MS; Gómez-Dávila R
Rev Med Inst Mex Seguro Soc; 2010; 48(3):313-6. PubMed ID: 21192905
[TBL] [Abstract][Full Text] [Related]
14. Comparison of photodynamic therapy with two different parameters combined with subconjunctival injection of bevacizumab for corneal neovascularization.
Yin XF; Wu MH; Jin CJ; Zhou SY
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104067. PubMed ID: 38548042
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of corneal neovascularization with verteporfin.
Fossarello M; Peiretti E; Zucca I; Serra A
Cornea; 2003 Jul; 22(5):485-8. PubMed ID: 12827058
[TBL] [Abstract][Full Text] [Related]
16. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
[TBL] [Abstract][Full Text] [Related]
17. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.
Lam DS; Liu DT; Fan DS; Lai WW; So SF; Chan WM
Eye (Lond); 2005 Aug; 19(8):834-40. PubMed ID: 15375364
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]